Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
CIPLA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty 100 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Cipla's Board approved audited consolidated results for FY25 with revenue from operations at Rs 27,547.62 crores, up about 6.9% from Rs 25,774.09 crores in FY24. Net profit jumped to Rs 5,269.20 crores versus Rs 4,153.72 crores, a growth of roughly 27%, translating to EPS of Rs 65.29 (vs Rs 51.05). Q4 FY25 was strong with revenue of Rs 6,729.69 crores and net profit of Rs 1,214.14 crores, up about 30% year-on-year. The Board recommended a final dividend of Rs 13 per share plus a special dividend of Rs 3 per share to mark Cipla's 90th anniversary, taking the total to Rs 16 per share, with a record date of June 27, 2025. The statutory auditor (Walker Chandiok & Co LLP) issued an unmodified opinion on the results.
Solid double-digit profit growth and a generous total dividend (Rs 16/share, including a one-time special dividend) are positive for shareholders and likely supportive of the stock in the near term, though revenue growth was single-digit.